Cargando…
Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims
We identified 38 businesses advertising purported stem cell interventions and exosome products for COVID-19. These companies operated or facilitated access to 60 clinics. More than 75% of these clinics were based in the United States and Mexico. Thirty-six of the businesses marketed their stem cell...
Autores principales: | Turner, Leigh, Martinez, Juan Ramon, Najjar, Shemms, Rajapaksha Arachchilage, Thevin, Wang, Jia Chieng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679647/ https://www.ncbi.nlm.nih.gov/pubmed/37890484 http://dx.doi.org/10.1016/j.stemcr.2023.09.015 |
Ejemplares similares
-
Labeling compliance and online claims for Ayurvedic herbal supplements on the U.S. market associated with the purported treatment of COVID-19
por: Jordan, Chevon R., et al.
Publicado: (2023) -
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
por: Turner, Leigh
Publicado: (2020) -
Direct-to-consumer Marketing to People with Hemophilia
por: Kucab, Philip, et al.
Publicado: (2016) -
False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland
por: Crane, Matthew A., et al.
Publicado: (2023) -
Oral nicotine marketing claims in direct-mail advertising
por: Czaplicki, Lauren, et al.
Publicado: (2022)